New Treatments for Alzheimer's on t... (rugs how we think about amyloid or both....)

New Treatments for Alzheimer's on the Horizon

Date:7/15/2009

rugs, how we think about amyloid, or both."

It could be that Dimebon neutralizes then expels the excess amyloid from the brain, or that there is actually some benefit to having amyloid outside the neuron as opposed to inside (where it might be more toxic), Gandy postulated.

And it's entirely possible that beta amyloid is not the main culprit in Alzheimer's. "It's not clear that amyloid is what's toxic to the neurons and it may be that Dimebon is mobilizing the stuff to get it out of the system," said Dr. Gary Kennedy, director of geriatric psychiatry at Montefiore Medical Center in New York City. "Amyloid may be a nasty traveling companion rather than the assassin."

There has been no hint yet that the elevation in beta amyloid levels produces undesirable side effects.

Pharmaceutical companies are working aggressively to move this drug towards a U.S. Food and Drug Administration approval, said Dr. Ralph Nixon, vice chair of the Alzheimer's Association Medical & Scientific Advisory Council.

"Especially if the drug is confirmed to be efficacious in Phase 3 trials, I think this will be a very strong tool to find clues as to what the basic cause of the disease is and some of the factors leading to the development of Alzheimer's," Nixon said. "Some of those factors may be independent of beta amyloid but it's too early to say that. But it certainly raises some interesting thinking about possible other factors that might be targetable as new drug therapies."

A second study found that a vaccine that targets the neurofibrillary "tau" tangles seen in Alzheimer's brains did actually reduce levels of the structure, at least in mice.

Until now, researchers haven't had much success with amyloid immunization or even with previous experiments with tau vaccines, which have caused brain inflammation in past research.

The Israeli researchers immunized mice who had been genetically engineered to develop
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Drug-free treatments offer hope for older people in pain
2. Updated Brochure on Gynecologic Cancer Treatments Now Available
3. Plastic Surgery 2007: Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances
4. ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
5. Better Lupus Treatments on the Horizon
6. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
7. Acupuncture School Gives Free Acupuncture Treatments
8. Value of Most Post-Traumatic Stress Treatments Uncertain
9. Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting
10. Genes Unlock New Treatments for Deadly Melanoma
11. Patient navigators help minority, low-income cancer patients get life-saving treatments

Post Your Comments:

Related Image:

New Treatments for Alzheimer's on the Horizon

(Date:12/15/2009)... release of a new report titled, “Incontinence Devices Markets Worldwide.” ... used to treat and manage urinary incontinence. , ... ... Marketstrat is pleased to announce the release of a new ... addresses world markets for clinical devices used to treat and ...

(Date:12/14/2009)... Young Adults, Attitudes and Behavior Regarding Pregnancy, Contraception, and ... -- Nearly all unmarried young adults ages 18-29 believe ... men and 86% of women) and say that it ... now (86% of men and 88% of women), according ... Prevent Teen and Unplanned Pregnancy. Even so: ,, ...

(Date:12/14/2009)... and HOLLYWOOD, Fla., Dec. 14 ... today a definitive agreement to acquire STARLIMS ... leading provider of laboratory information management systems, ... ,, The acquisition strengthens Abbott,s competitive position ... web-based applications to help laboratories efficiently store, ...

(Date:12/14/2009)... The National Organization for Rare Disorders (NORD) ... to lifetime and annual health insurance caps. In ... newspaper distributed widely on Capitol Hill, NORD said the ... allow caps to continue for most Americans, contrary to ... care reform and welcomes the promises made by President ...

(Date:12/14/2009)... years under government controlled health care, before moving to the U.S. ... and in his new book, Health Reform: The End of the ... system and its threat to real health care! , ... ... diagnostic radiologist from Minnesota, warns Americans not to sell out their ...

Breaking Medicine News(10 mins):Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2 Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3 Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2 Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3 Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2 Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3 Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4 Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2 Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2

[0] Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail [1] Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference [0] Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems [0] NORD Calls for Immediate End to Lifetime Insurance Caps [2] Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America

... The Westaim Corporation,announced today that for the first quarter ended ... or 7 cents per share, on revenues of,$5.2 million. In ... of $6.7 million, or 7 cents per share, on revenues ... million for the quarter,compared to $1.9 million in the same ...

... the University of Michigan Comprehensive Cancer Center have found ... more likely to survive cancers of the base of ... found that cancers linked to HPV, or human papillomavirus, ... treatments, while tumors that express high levels of a ...

... Graduate Institute (KGI),today announced that the May 17, 2008, ... in Applied Life Sciences student, Eric,Tan, and the unveiling ... excited and proud of Eric,s achievement in becoming the,first ... Dewey, KGI,s senior,vice president for academic affairs, dean of ...

... VANCOUVER, May 12 /PRNewswire-FirstCall/ - Cardiome Pharma Corp.,(NASDAQ: CRME ... financial,results for the first quarter of 2008 on the ... teleconference call and webcast at 4:30pm,Eastern (1:30pm Pacific) on ... the conference call, please dial 416-641-6117 or,866-299-6655. There will ...

... Slides at 5pm Today, LAWRENCE, Mass., May 12 ... manufacturer of innovative dialysis products,today announced its financial results ... for the first quarter of 2008 were $31.0 million, ... and $29.9 million in the fourth,quarter of 2007. Revenues ...

... - SXC Health Solutions, Corp.,(NASDAQ: SXCI , TSX: ... healthcare IT solutions, announced today that its,2007 Annual Meeting ... 2008 at,5:30 p.m. Eastern Time/4:30 p.m. Central Time at ... The presentation will be webcast live. To access the ...

Westaim announces 2008 first quarter results HPV linked to better survival in tonsil, tongue cancer, U-M study finds KGI 2008 Commencement Features First PhD Graduate, Biotech Painting Cardiome To Release 2008 First Quarter Results NxStage Medical Reports First Quarter 2008 Results SXC Health Solutions to host annual meeting of shareholders May 12, 2008 at 5:30 pm ET/4:30 pm CT

(Date:12/14/2009)... THE WOODLANDS, Texas, Dec. 14 /PRNewswire/ ... investigators affiliated with US Oncology ... were presented orally at the ... , held Dec. 9-13 at the ... in San Antonio, Texas . ...

(Date:12/14/2009)... Health today announced that executives of the company will ... Goldman Sachs CEO Unplugged Conference on Jan. 6 ... in New York. 28th Annual J.P. Morgan ... at the Westin St. Francis Hotel in San Francisco. ... Cardinal Health,s diverse products and services, company performance and ...

(Date:12/14/2009)... Dec. 14 Southridge LLC ("Southridge"), ... micro-cap companies, is pleased to announce that its affiliated ... up to $15 million in equity financing to Imaging ... the years of financing the growth of Imaging Diagnostic ... continually produce new developments in the field of early ...

Breaking Medicine Technology:US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 2 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 3 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 4 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 5 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 6 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 7 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 8 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 9 Cardinal Health Executives to Speak at Two Investor Events in January 2 Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2 Spike Footballs this Fall Without Straining the Spine 54231 1 Spike Footballs this Fall Without Straining the Spine 54231 2 Leading Medical Developer Announces Plans for Texoma Medical Plaza 54227 1 Leading Medical Developer Announces Plans for Texoma Medical Plaza 54227 2 Leading Medical Developer Announces Plans for Texoma Medical Plaza 54227 3 ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology 4846 1 ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology 4846 2 ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology 4846 3

[0] US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium [0] Cardinal Health Executives to Speak at Two Investor Events in January [0] Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc.

... SAN DIEGO, Jan. 22 Meritage Pharma, Inc. announced ... clinical trial to evaluate oral viscous budesonide (OVB) for ... (EoE), an allergic inflammatory condition of the esophagus. EoE ... severe cases it can lead to food impaction (food ...

... January 21 PharmaSurgics AB has,received approval from ... phase,I clinical documentation with the novel candidate drug, ... will be initiated in,March 2009. , ... that connect anatomic structures that,should not normally be ...

Other Medicine Technology:Meritage Pharma Initiates Phase 2b Clinical Trial of Oral Viscous Budesonide for Pediatric Patients With Eosinophilic Esophagitis 2 Meritage Pharma Initiates Phase 2b Clinical Trial of Oral Viscous Budesonide for Pediatric Patients With Eosinophilic Esophagitis 3 Novel Product for Post Surgical Scar Formation Entering Clinical Development 2

Meritage Pharma Initiates Phase 2b Clinical Trial of Oral Viscous Budesonide for Pediatric Patients With Eosinophilic Esophagitis Novel Product for Post Surgical Scar Formation Entering Clinical Development

... Durable ergonomic chairs with concave seats ... • Select options like seats, backrests, ... Choose the BE Series for top ... including: industry, education, laboratory, clean room, ...

... chairs with concave seats and large backrests ... seats, backrests, armrests, and casters and glides. ... performance in a variety of environments including: ... health care and office. • With cast ...

... chairs with concave seats and large ... options like seats, backrests, armrests, and ... BE Series for top performance in ... education, laboratory, clean room, static control, ...

... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...

Medicine Products:

BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q43-CAB-ERB BEC/1Q-ERB - Cast Aluminum Base - Model 1Q66-R-ERB BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q70-CAB-ERB BEC/1Q-ERB - Cast Aluminum Base - Model 1Q73-ERB

New Treatments for Alzheimer's on t...(rugs how we think about amyloid or both....),Health